(Q34163164)

31 July 2017

1 reference

title

Effects of inhibition of the renin-angiotensin system on the cardiovascular actions of insulin (English)

1 reference

31 July 2017

1 reference

1 reference

Katovich MJ

1

1 reference

31 July 2017

Pachori A

series ordinal

2

1 reference

31 July 2017

publication date

1 January 2000

1 reference

Diabetes, Obesity and Metabolism

31 July 2017

published in

1 reference

31 July 2017

volume

2

1 reference

31 July 2017

issue

1

1 reference

31 July 2017

page(s)

3-14

1 reference

Hyperinsulinemia. A link between hypertension obesity and glucose intolerance

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

Essential hypertension, metabolic disorders, and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

Insulin resistance, hyperinsulinemia, and hypertriglyceridemia in the etiology and clinical course of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

Postpartum abnormalities of carbohydrate and cellular calcium metabolism in pregnancy induced hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

Mechanisms in obesity-related hypertension: role of insulin and catecholamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

Sympathetic response to oral carbohydrate administration. Evidence from microelectrode nerve recordings

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

The sympathetic response to euglycaemic hyperinsulinaemia. Evidence from microelectrode nerve recordings in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

Atherosclerosis and the arterial smooth muscle cell: Proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

Altered regulation of renin secretion by insulinlike growth factors and angiotensin II in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

Reduced proximal tubule angiotensin II receptor expression in streptozotocin-induced diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

Is hypertension an insulin-resistant state? Metabolic changes associated with hypertension and antihypertensive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

Skeletal muscle blood flow. A possible link between insulin resistance and blood pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

Effects of angiotensin receptor antagonist and angiotensin converting enzyme inhibitor on insulin sensitivity in fructose-fed hypertensive rats and essential hypertensives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalk

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

Angiotensin receptor blockade blunts hyperinsulinemia-induced hypertension in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

Role of angiotensin II in hyperinsulinemia-induced hypertension in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

Blockade of angiotensin II receptors inhibits the increase in blood pressure induced by insulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

Angiotensin II affects basal, pulsatile, and glucose-stimulated insulin secretion in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

Insulin Resistance in Secondary Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

Resistance to Insulin-Stimulated-Glucose Uptake in Patients with Hypertension*

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

Effect of Weight Loss without Salt Restriction on the Reduction of Blood Pressure in Overweight Hypertensive Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

Anteroventral third ventricle lesions abolish lumbar sympathetic responses to insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

Chronic hyperinsulinemia and blood pressure. Interaction with catecholamines?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

Increased proximal tubular sodium reabsorption in hypertensive patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

Insulin as a vascular hormone: implications for the pathophysiology of cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

Cardiovascular actions of insulin: are they important in long-term blood pressure regulation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

Insulin-induced vasodilatation: physiology or pharmacology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

Insulin induces upregulation of vascular AT1 receptor gene expression by posttranscriptional mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

Relation of pressor responsiveness to angiotensin II and insulin resistance in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

Effect of insulin on the proliferation of cultured primate arterial smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

Receptors and growth-promoting effects of insulin and insulinlike growth factors on cells from bovine retinal capillaries and aorta

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

The angiotensin-II receptor antagonist, losartan, inhibits LDL lipid peroxidation and atherosclerosis in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

Angiotensin, LDL peroxidation and atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

Prevention of intimal thickening after endothelial removal by a nonpeptide angiotensin II receptor antagonist, losartan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

Hypertension therapy and risk of coronary heart disease: how do antihypertensives affect metabolic factors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

Excess Mortality Associated With Diuretic Therapy in Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

The calcium messenger system (1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

Vanadyl sulfate prevents fructose-induced hyperinsulinemia and hypertension in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

Fructose-induced insulin resistance and hypertension in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

Somatostatin inhibition of fructose-induced hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

Role of angiotensin II in high fructose-induced left ventricular hypertrophy in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

Vascular reactivity to phenylephrine and angiotensin II in hypertensive rats associated with insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

Effects of losartan on blood pressure, metabolic alterations, and vascular reactivity in the fructose-induced hypertensive rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

Inhibition of the translocation of GLUT1 and GLUT4 in 3T3-L1 cells by the phosphatidylinositol 3-kinase inhibitor, wortmannin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

Role of phosphatidylinositol-3-kinase in insulin receptor signaling: studies with inhibitor, LY294002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

Phosphorylation of insulin receptor substrate-1 on multiple serine residues, 612, 632, 662, and 731, modulates insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

Cross-talk between the insulin and angiotensin signaling systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

Effects of angiotensin II-receptor blockade with losartan on insulin sensitivity, lipid profile, and endothelin in normotensive offspring of hypertensive parents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

Blockade of angiotensin converting enzyme but not of angiotensin AT1 receptors improves glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

Captopril does not improve insulin action in essential hypertension: a double-blind placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00044.X

Effect of captopril, losartan, and bradykinin on early steps of insulin action

21 January 2018

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.2337/DIAB.46.12.1950

Identifiers

DOI

10.1046/J.1463-1326.2000.00044.X

1 reference

31 July 2017

1 reference